Page last updated: 2024-08-25

siagoside and g(m1) ganglioside

siagoside has been researched along with g(m1) ganglioside in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (20.00)	18.7374
1990's	8 (53.33)	18.2507
2000's	4 (26.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonanno, G; Fedele, E; Marchi, M; Raiteri, M; Versace, P	1
Agnati, LF; Biagini, G; Fuxe, K; Grimaldi, R; Merlo Pich, E; Solfrini, V; Toffano, G; Zoli, M	1
Agnati, LF; Fuxe, K	1
Emerich, DF; Walsh, TJ	3
Aldinio, C; Borzeix, MG; Cahn, J; Cahn, R; Toffano, G	1
Bertazzo, A; Colombo, C; Galli, C; Petroni, A; Sarti, S	1
Cardell, M; Wieloch, T	1
Dunbar, GL; Lescaudron, LL; Stein, DG	1
Coleman, WP; Geisler, FH; Grieco, G; Poonian, D	3
Bracken, MB; Fehlings, MG	1

Reviews

1 review(s) available for siagoside and g(m1) ganglioside

Article	Year
Nigrostriatal dopamine neurons, D1 transmission in basal and ischemic states and protective effects of gangliosides. Laboratory investigation; a journal of technical methods and pathology, 1990, Volume: 63, Issue:3 Topics: Antibodies; Autoradiography; Benzazepines; Cholera Toxin; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Glial Fibrillary Acidic Protein; Ischemic Attack, Transient; Nerve Tissue Proteins; Ornithine Decarboxylase; Phosphoproteins; Phosphorylation; Putrescine; Receptors, Dopamine; Receptors, Neurotransmitter; Reperfusion; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase	1990

Article

Year

Nigrostriatal dopamine neurons, D1 transmission in basal and ischemic states and protective effects of gangliosides.

Laboratory investigation; a journal of technical methods and pathology, 1990, Volume: 63, Issue:3

Topics: Antibodies; Autoradiography; Benzazepines; Cholera Toxin; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Glial Fibrillary Acidic Protein; Ischemic Attack, Transient; Nerve Tissue Proteins; Ornithine Decarboxylase; Phosphoproteins; Phosphorylation; Putrescine; Receptors, Dopamine; Receptors, Neurotransmitter; Reperfusion; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase

1990

Trials

1 trial(s) available for siagoside and g(m1) ganglioside

Article	Year
The Sygen multicenter acute spinal cord injury study. Spine, 2001, Dec-15, Volume: 26, Issue:24 Suppl Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; G(M1) Ganglioside; Humans; Logistic Models; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Recovery of Function; Spinal Cord Injuries; Treatment Outcome	2001

Other Studies

13 other study(ies) available for siagoside and g(m1) ganglioside

Article	Year
Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration. European journal of pharmacology, 1992, Mar-17, Volume: 213, Issue:1 Topics: Acetylcholine; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male; Rats; Rats, Inbred Strains; Sulpiride	1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats. Stroke, 1992, Volume: 23, Issue:2 Topics: Animals; Apomorphine; Behavior, Animal; Brain; Brain Ischemia; Choice Behavior; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Germ-Free Life; Hippocampus; Male; Memory Disorders; Nerve Tissue Proteins; Phosphoproteins; Prosencephalon; Rats; Rats, Inbred Strains; Stereotyped Behavior	1992
Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine. Experimental neurology, 1991, Volume: 112, Issue:3 Topics: Animals; Behavior, Animal; Cell Survival; Choline O-Acetyltransferase; Colchicine; G(M1) Ganglioside; Injections, Intraventricular; Locomotion; Male; Memory Disorders; Rats	1991
Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A. Brain research, 1990, Sep-17, Volume: 527, Issue:2 Topics: Acetylcholinesterase; Animals; Aziridines; Cerebral Ventricles; Choline; Choline O-Acetyltransferase; G(M1) Ganglioside; Hippocampus; Injections, Intraventricular; Learning; Male; Memory; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains; Reference Values; Space Perception	1990
Influence of monosialoganglioside inner ester on neurologic recovery after global cerebral ischemia in monkeys. Stroke, 1989, Volume: 20, Issue:5 Topics: Animals; Blood Glucose; Brain; Cerebrovascular Circulation; Coma; Female; G(M1) Ganglioside; Ischemic Attack, Transient; Macaca fascicularis; Male; Random Allocation	1989
Selective working memory impairments following intradentate injection of colchicine: attenuation of the behavioral but not the neuropathological effects by gangliosides GM1 and AGF2. Physiology & behavior, 1989, Volume: 45, Issue:1 Topics: Animals; Colchicine; Discrimination Learning; G(M1) Ganglioside; Hippocampus; Injections; Male; Memory; Mental Recall; Nerve Regeneration; Orientation; Rats; Rats, Inbred Strains; Retention, Psychology	1989
Effects of gangliosides on the formation of eicosanoids in rat brain cerebral ischemia and reperfusion. Pharmacological research communications, 1988, Volume: 20 Suppl 5 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Brain; Brain Ischemia; Cell Membrane Permeability; G(M1) Ganglioside; Lactates; Male; Rats; Rats, Inbred Strains; Reperfusion; Thromboxane B2	1988
Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat. Journal of neurochemistry, 1993, Volume: 61, Issue:4 Topics: Animals; Biological Transport; Brain Ischemia; G(M1) Ganglioside; Isoenzymes; Male; Protein Kinase C; Rats; Rats, Wistar; Subcellular Fractions; Time Factors	1993
Comparison of GM1 ganglioside, AGF2, and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum. Behavioural brain research, 1993, Mar-31, Volume: 54, Issue:1 Topics: Adenosine Monophosphate; Animals; Brain Mapping; Cell Count; Dextroamphetamine; Discrimination Learning; Electroshock; G(M1) Ganglioside; Injections, Intraperitoneal; Male; Neostriatum; Neuroglia; Neurons; Orientation; Rats; Rats, Sprague-Dawley; Reversal Learning; Sensory Thresholds	1993
Siagoside. GM1, Sygen. Drugs in R&D, 1999, Volume: 1, Issue:1 Topics: Acute Disease; Animals; Antiparkinson Agents; Brain Ischemia; Drugs, Investigational; G(M1) Ganglioside; Humans; Neuroprotective Agents; Parkinson Disease; Stroke	1999
Recruitment and early treatment in a multicenter study of acute spinal cord injury. Spine, 2001, Dec-15, Volume: 26, Issue:24 Suppl Topics: Acute Disease; Adolescent; Adult; Aged; Decompression, Surgical; Female; G(M1) Ganglioside; Humans; Male; Middle Aged; Neuroprotective Agents; North America; Patient Selection; Randomized Controlled Trials as Topic; Retrospective Studies; Spinal Cord Injuries; Time Factors	2001
Measurements and recovery patterns in a multicenter study of acute spinal cord injury. Spine, 2001, Dec-15, Volume: 26, Issue:24 Suppl Topics: Adolescent; Adult; Aged; Female; G(M1) Ganglioside; Humans; Male; Middle Aged; Neuroprotective Agents; North America; Prognosis; Randomized Controlled Trials as Topic; Recovery of Function; Retrospective Studies; Severity of Illness Index; Spinal Cord Injuries	2001
Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury. Spine, 2001, Dec-15, Volume: 26, Issue:24 Suppl Topics: Acute Disease; G(M1) Ganglioside; Humans; Multicenter Studies as Topic; Neuroprotective Agents; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Treatment Outcome	2001